A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
10/09/2019 - 9 minutes
Leukemia
Update: French Biotech Considers Takeover After Failed Leukemia Drug Trial
Update (14/01/2019): An anonymous French company on Euronext has made an offer to take over…
14/01/2019 - 2 minutes
Engineering Red Blood Cells to Fight the Most Severe Cancers
Our very own red blood cells could soon become a treatment for some of the…
21/05/2018 - 6 minutes
“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“
Celyad has reported clinical results showing the first time a patient has fully recovered from…
19/04/2018 - 3 minutes
This Spanish Biotech Is Developing Stem-Cell Targeted Leukemia Treatments
This week, we're in Barcelona, Spain, to visit Leukos Biotech, whose goal is to develop…
02/03/2018 - 2 minutes
Novartis Takes Genmab’s Leukemia Drug Off the Market
Genmab's leukemia drug will be available around the world through compassionate use programs, while it will…
22/01/2018 - 3 minutes
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy…
13/12/2017 - 4 minutes
New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
11/12/2017 - 3 minutes
Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching
Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors…
04/12/2017 - 2 minutes
Update: French Red Blood Cell Biotech Enters Nasdaq with a $144M IPO
Update (15/11/2017): Erytech has closed its Nasdaq IPO raising a total of $144M (€122M) despite…
15/11/2017 - 2 minutes
Update: Clinical Holds Lifted for First Off-the-Shelf CAR-T Therapy
UPDATE: The FDA has lifted both clinical holds provided that Cellectis decreases the dose of…
07/11/2017 - 3 minutes
The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’
Gilead's CAR-T cell therapy Yescarta has been approved by the FDA, making it the first…
19/10/2017 - 3 minutes
